MesoTV | NOW ENROLLING: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

We are joined by Dr. Aaron Mansfield of the Mayo Clinic to discuss a new, now enrolling, clinical trial for peritoneal mesothelioma that randomizes patients into two arms: an arm that receives chemotherapy + bevacizumab, and an arm that receives chemotherapy, bevacizumab and immunotherapy.

Om Podcasten

The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life. The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by: funding research to improve treatment options; providing treatment support and education for patients and their families; and advocating for federal funding of research.